Sg Americas Securities, LLC Supernus Pharmaceuticals, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 10,804 shares of SUPN stock, worth $421,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,804Holding current value
$421,247% of portfolio
0.0%Shares
26 transactions
Others Institutions Holding SUPN
# of Institutions
298Shares Held
61.1MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$405 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$240 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$199 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$112 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$103 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.09B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...